Revisit of Polyomavirus Nephropathy Grading in Renal Allograft Recipients According to the Banff 2019 Working Group Classification: A Study From a Large Transplant Center in South India.
banff 2019 classification
bk virus
clinical presentation
histopathology
outcome
polyomavirus nephropathy
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
accepted:
18
02
2022
entrez:
24
3
2022
pubmed:
25
3
2022
medline:
25
3
2022
Statut:
epublish
Résumé
Background In renal transplant patients, the biopsy-proven incidence of polyomavirus nephropathy (PVN) is approximately 5%. There is no consensus in the morphologic classification of definitive PVN, which is attempted in the Banff 2019 Working Group classification, which groups histologic changes, reflects clinical presentation, and facilitates comparative outcome analyses. This study aims to analyze the clinical and histopathological findings and outcomes among the three classes in the recent classification. Materials and methods The study was conducted in the department of pathology and nephrology over a period of six years. All cases diagnosed as PVN on renal allograft biopsies were included. The clinical and biochemical findings were obtained from hospital records. Histopathology slides were reviewed and classified according to Banff 2019 criteria and were analyzed with clinical, laboratory, histopathological parameters along with the clinical outcome. Results Out of 205 renal transplants performed during the study period, 14 patients (6.8%) were diagnosed with PVN. The mean age of diagnosis was 38 years, with a Male: Female ratio of 1.8:1. The median period of diagnosis of the viral infection after transplant was 10 months. Histomorphology grading according to Banff 2019 revealed four cases (28.5%) in PVN class 1, eight cases (57.2%) in PVN class 2, and two cases (14.3%) in PVN class 3. Cases in PVN class 1 presented early. PVN class 1 was associated with a single type of inclusion, and multiple type inclusions were observed in higher classes. Associated diseases were thrombotic microangiopathy (TMA), borderline cellular rejection, antibody-mediated rejection (ABMR), and concomitant infections. PVN class 1 had a better outcome compared to PVN class 2 and class 3. Conclusion PVN1 was observed to have better clinical presentation and outcomes than PVN2 and 3; however, this could not be statistically concluded due to the low sample size and other associated diseases.
Identifiants
pubmed: 35321062
doi: 10.7759/cureus.22377
pmc: PMC8935362
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e22377Informations de copyright
Copyright © 2022, Subramanian et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Am Soc Nephrol. 1999 May;10(5):1080-9
pubmed: 10232695
J Am Soc Nephrol. 2018 Feb;29(2):680-693
pubmed: 29279304
Am J Transplant. 2001 Nov;1(4):373-81
pubmed: 12099383
N Engl J Med. 2002 Aug 15;347(7):488-96
pubmed: 12181403
Am J Transplant. 2012 Apr;12(4):907-18
pubmed: 22390378
BMC Infect Dis. 2016 Jul 22;16:342
pubmed: 27448566
Am J Transplant. 2013 Mar;13 Suppl 4:179-88
pubmed: 23465010
Indian J Pathol Microbiol. 2010 Oct-Dec;53(4):672-5
pubmed: 21045390
Transplantation. 2004 Feb 15;77(3):429-31
pubmed: 14966420
Am J Transplant. 2021 Feb;21(2):669-680
pubmed: 32654412
Am J Kidney Dis. 1995 Oct;26(4):671-3
pubmed: 7573026
Clin J Am Soc Nephrol. 2012 Aug;7(8):1320-7
pubmed: 22626962